Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-10

Clinical Trial Update: Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy. [Phase 4]

View source ↗

Summary

Phase 4 trial update on the efficacy of L-Ornithine L-Aspartate for hepatic encephalopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-ornithine-L-aspartate (L-ornithine-L-aspartate)

Snippet

Sponsor: Centro Regional para el Estudio de las Enfermedades Digestivas | Conditions: Hepatic Encephalopathy | Phase 4 | Status: COMPLETED